Express Healthcare
Home  »  Medical Devices As Drugs  »  Medical devices as drugs

Medical devices as drugs

0 183
Read Article

Experts share their views and insights on the impact and implications on this move by MoH&FW

We welcome the government’s decision to regulate all devices

Pavan Choudary, Chairman and Director General, Medical Technology Association of India (MTaI)

We welcome the government’s decision to regulate all devices, which has also been a long-standing ask of the industry. These regulations, that are a continuation of the Medical Devices Rules 2017, which were launched after meticulous deliberations for two years, are in line with the government’s vision to provide equitable access to quality healthcare. We are also happy that the health ministry is recruiting competent resources to cater to the additional workload that these new regulations will bring.

We appreciate the Indian government’s decision to regulate all medical devices

Abby Pratt, Vice President, AdvaMed

AdvaMed and its member companies appreciate Indian government’s decision to regulate all medical devices under the guidelines issued by the Ministry of Health as per the Medical Devices Rules 2017 and strengthen regulations to improve safety and quality of products available in India. We believe this decision to make norms more stringent and the Ministry of Health’s investment in capacity building by recruitment of specialised auditors will benefit the medical devices industry and the patients at large. We congratulate MoH&FW for its efforts to support Prime Minister Narendra Modi’s ‘Make in India’ initiative by globally harmonising India’s regulatory structure, which will enable domestic manufacturers of medical devices and IVDs to make in India for the world. It will prove pivotal in enabling a more predictable pathway for globally recognised technology to enter India and lessen the gap between India’s access to research-based medical devices and diagnostics.

The move will ensure that all medical devices available will be safe and effective

Himanshu Baid, Chairman, CII Medical Technology Division and Managing Director, Polymedicure

CII Medical Technology Division welcomes this move, as this will ensure that all medical devices available will be safe and effective. The temporary registration application for devices that are currently unregulated will require basic administrative documents and product information. The registration process carries no government processing fees and does not expire till the manufacturer/importer obtain the import/manufacturing licence within a period of 36 and 42 months for class A,B and C,D devices respectively. The temporary registration may be cancelled or suspended by the CDSCO for product safety concerns, or when superseded by an Import/ Manufacturing License. Once registered, the local registration holder will be required to notify the CDSCO and Materiovigilance Programme of India (MvPi) of Serious Adverse Events (SEA) occurring in India.

The move will be positive for domestic manufacturers and boost exports
Dr GSK Velu, Chairman & MD, Trivitron Healthcare
It is a good move that will lead to a consolidation in the sector. This will discourage the refurbished equipment and grey-channel imports. In turn, this will be positive for domestic manufacturers and boost exports

Leave A Reply

Your email address will not be published.